Literature DB >> 10213365

Degradation and aggregation of human calcitonin in vitro.

R H Lu1, P Kopecková, J Kopecek.   

Abstract

PURPOSE: To investigate the degradation of human calcitonin (hCT) by enzymes or mucosa from different gastrointestinal (GI) compartments and evaluate the stabilization effect of a synthetic ionizable copolymer on the stability of hCT in an aqueous solution. These data are a prerequisite for the development of a hydrogel based colon-specific hCT delivery system.
METHODS: Luminal and brush border membrane (BBM) enzymes from the colon and small intestine (SI) of the rabbit were isolated and their enzymatic activity toward hCT in vitro was evaluated. Human fecalase was used to mimic the luminal enzymatic activity in the human colon and its degradation ability was assessed. Excised intact rabbit intestinal tissues from both the colon and the SI were used to study the degradation patterns of hCT by intact mucosa. Detection of intact human calcitonin was performed using gradient elution, reverse phase high-pressure liquid chromatography (RP-HPLC). The structure of the hCT fragments was determined by Matrix Assisted Laser Desorption/lonization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) analysis. UV/VIS and fluorescence spectroscopy methods were used to evaluate the influence of a copolymer, possessing the same structure as the primary chains in hydrogels degradable in the colon, on the fibrillation process of hCT.
RESULTS: In vitro results showed that isolated luminal enzymes and BBM enzymes from the SI were more potent in degrading intact hCT, as expected. Moreover, BBM enzymes were far more abundant in the SI than in the colon. Compared with rabbit colonic luminal enzymes, the degradation potency of human fecalase was further abated. Intact mucosal studies revealed extensive degradation by the SI mucosa but not by the colonic mucosa. The primary structures of the peptide fragments were identified by MALDI-TOF MS analysis. Fibrillation studies of hCT indicated that acrylic acid-containing polymeric materials were able to decrease the aggregation of hCT in aqueous solutions.
CONCLUSIONS: Reduced proteolytic activity suggests that the colon is an advantageous site for peptide delivery. The structures of hCT degradation products were identified and the participation of particular enzymes in the degradation process was suggested. In addition, it was determined that an acrylic acid-containing copolymer improved the physical stability of hCT in aqueous solution.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10213365     DOI: 10.1023/a:1018813416523

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Significance of microflora in proteolysis in the colon.

Authors:  S A Gibson; C McFarlan; S Hay; G T MacFarlane
Journal:  Appl Environ Microbiol       Date:  1989-03       Impact factor: 4.792

2.  Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of postmenopausal osteoporosis.

Authors:  R Muff; M A Dambacher; J A Fischer
Journal:  Osteoporos Int       Date:  1991-02       Impact factor: 4.507

Review 3.  The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.

Authors:  A Bernkop-Schnürch
Journal:  J Control Release       Date:  1998-03-02       Impact factor: 9.776

4.  Novel pH-sensitive hydrogels with adjustable swelling kinetics.

Authors:  E O Akala; P Kopecková; J Kopecek
Journal:  Biomaterials       Date:  1998-06       Impact factor: 12.479

5.  Proteolysis of human calcitonin in excised bovine nasal mucosa: elucidation of the metabolic pathway by liquid secondary ionization mass spectrometry (LSIMS) and matrix assisted laser desorption ionization mass spectrometry (MALDI).

Authors:  S R Lang; W Staudenmann; P James; H J Manz; R Kessler; B Galli; H P Moser; A Rummelt; H P Merkle
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

6.  The structure and mechanism of formation of human calcitonin fibrils.

Authors:  T Arvinte; A Cudd; A F Drake
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

7.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

8.  A new approach to the oral administration of insulin and other peptide drugs.

Authors:  M Saffran; G S Kumar; C Savariar; J C Burnham; F Williams; D C Neckers
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

9.  Functionalized semitelechelic poly[N-(2-hydroxypropyl)methacrylamide] for protein modification.

Authors:  Z R Lu; P Kopecková; Z Wu; J Kopecek
Journal:  Bioconjug Chem       Date:  1998 Nov-Dec       Impact factor: 4.774

10.  Enhanced potency of human calcitonin when fibrillation is avoided.

Authors:  A Cudd; T Arvinte; R E Das; C Chinni; I MacIntyre
Journal:  J Pharm Sci       Date:  1995-06       Impact factor: 3.534

View more
  2 in total

1.  Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58).

Authors:  Rachel Tréhin; Hanne M Nielsen; Heinz-Georg Jahnke; Ulrike Krauss; Annette G Beck-Sickinger; Hans P Merkle
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

2.  Regional peptide uptake study in the rat intestinal mucosa: glatiramer acetate as a model drug.

Authors:  Susan Haupt; Efrat Gil; Regin Tirosh; Ety Klinger; Alexander Gad; Abraham Rubinstein
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.